Intuitive Surgical (ISRG) Form 144 Filed for 335-Share Sale
Rhea-AI Filing Summary
Intuitive Surgical Inc. (ISRG) Form 144 shows a proposed sale of 335 shares of common stock through Morgan Stanley Smith Barney with an aggregate market value of $147,631.15, targeted for 09/04/2025. The shares were acquired as restricted stock on 04/25/2024 from the issuer. The filer represents no undisclosed material information. The filing also reports a separate sale by Amy L. Ladd of 336 shares on 09/03/2025 for $157,956.96. The issuer's reported shares outstanding are 358,476,506, indicating these transactions represent a very small fraction of total equity.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider sale notice for a small number of shares relative to the company's outstanding equity; appears procedural.
The Form 144 documents a proposed sale of 335 restricted shares acquired on 04/25/2024, with an aggregate value of $147,631.15 and an intended sale date of 09/04/2025 via Morgan Stanley Smith Barney. Reported outstanding shares are 358,476,506, so the size of the proposed sale is immaterial to capital structure. The filing includes a reported sale by Amy L. Ladd of 336 shares on 09/03/2025 for $157,956.96. From a market-impact perspective, these volumes are negligible; the filing primarily serves disclosure and compliance purposes.
TL;DR: The notice fulfills Rule 144 disclosure requirements and records acquisition type and broker details; no material compliance issues evident.
The document specifies the nature of acquisition (restricted stock), acquisition date (04/25/2024), broker name and address, and the filer’s representation regarding material non-public information. It also records a recent actual sale by an identified seller with gross proceeds. The filing content is concise and contains the key elements required for a Rule 144 notice, consistent with standard insider sale reporting practices.
FAQ
What does Intuitive Surgical's (ISRG) Form 144 disclose?
Who acted as broker for the proposed ISRG sale?
How many ISRG shares were outstanding per the filing?
Was there a recent actual sale by an insider reported in this filing?
When were the proposed-to-be-sold shares acquired?